- Joined
- Jun 23, 2011
- Messages
- 60
My husband's GI wants to start him on Humira to try and get him into remission. (He was diagnosed with Crohn's about six years ago and has been on Entocort ever since, with Pentasa recently being added.) His colonoscopy in January showed that he has a stricture that has formed since the colonoscopy six years ago. I can't remember the size, but the doctor said he barely got the scope through and that if he were to have the capsule endoscopy now (which he doesn't need, but is how the Crohn's was originally diagnosed), it definitely would not go through.
Anyway, in my research I came across an article on preparing for biologic therapy and will post the paragraph & highlight the part that causes concern:
G&H Overall, what are the most important steps clinicians should take to prepare patients for biologic or immunomodulator therapy?
SVK First, clinicians need to make sure that they have identified the right patient for the drug. Many patients have irritable bowel syndrome or a known stricture, but they are prescribed a biologic agent anyway; in these cases, patients are being exposed to all of the drug's risks and getting none of its benefits. Once the clinician has decided that a patient truly has active IBD, then he or she needs to educate the patient about the risk-to-benefit profile of the drug. Part of the educational process is to explain all the therapeutic options that are available; in addition, patients need to understand that the goal of biologic or immunosuppressant therapy is to make them feel better, that steroids and narcotics are associated with worse outcomes if they are used long term, and that withholding therapy and allowing the disease to remain active leads to worse outcomes.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264940/
So, I was startled to read that and wanted to come here for opinions on what we should do. We already have insurance approval and the Humira nurse has left a voicemail about getting him started on his first dose, although it's not set up yet.
Thanks so much, and any input is appreciated!
Anyway, in my research I came across an article on preparing for biologic therapy and will post the paragraph & highlight the part that causes concern:
G&H Overall, what are the most important steps clinicians should take to prepare patients for biologic or immunomodulator therapy?
SVK First, clinicians need to make sure that they have identified the right patient for the drug. Many patients have irritable bowel syndrome or a known stricture, but they are prescribed a biologic agent anyway; in these cases, patients are being exposed to all of the drug's risks and getting none of its benefits. Once the clinician has decided that a patient truly has active IBD, then he or she needs to educate the patient about the risk-to-benefit profile of the drug. Part of the educational process is to explain all the therapeutic options that are available; in addition, patients need to understand that the goal of biologic or immunosuppressant therapy is to make them feel better, that steroids and narcotics are associated with worse outcomes if they are used long term, and that withholding therapy and allowing the disease to remain active leads to worse outcomes.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264940/
So, I was startled to read that and wanted to come here for opinions on what we should do. We already have insurance approval and the Humira nurse has left a voicemail about getting him started on his first dose, although it's not set up yet.
Thanks so much, and any input is appreciated!